US EditionUS health authorities to set targets for lowering drug prices
- On May 12, 2025, the U.S. Government announced an executive order aimed at establishing nationwide goals to reduce the cost of prescription medications.
- The order follows longstanding criticism of high US drug costs due to lack of government price negotiation, unlike other rich countries.
- The administration directs Medicare and Medicaid to benchmark reimbursement rates to prices in other developed nations and expects voluntary industry compliance.
- Health Secretary Kennedy noted American patients pay three to five times more for drugs, citing common cases like GLP-1 drugs costing $1,000 in the US versus $88 in London.
- If drug makers do not comply, regulators may propose rules for mandatory price caps, which could lower costs for patients but face political and industry resistance.
15 Articles
15 Articles
Spanberger: time to crack down on insurer practices that keep drug costs up
Democratic candidate for governor Abigail Spanberger wants to crack down on a range of insurer practices she says are keeping drug costs up, and hitting Virginians with abusive billing practices and scam coverage.
Feds preparing to roll out drug price targets
BOSTON (SHNS) - The federal government indicated Tuesday it has set specific targets to address a health care cost driver that Massachusetts policymakers are grappling with: prescription drugs. The U.S. Department of Health and Human Services said it identified targets that drug manufacturers are expected to meet to satisfy the requirements of President Trump's new executive order on drug pricing. "President Trump and Secretary Kennedy look for…
Coverage Details
Bias Distribution
- 55% of the sources are Center
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
